Can myeloma medications increase cataract development? This is a great question worth exploring.
Some myeloma treatments are known to affect the eyes, and certain medications — particularly corticosteroids like dexamethasone — are well-established contributors to cataract formation. Since dexamethasone is commonly used in Show Full Answer
Can myeloma medications increase cataract development? This is a great question worth exploring.
Some myeloma treatments are known to affect the eyes, and certain medications — particularly corticosteroids like dexamethasone — are well-established contributors to cataract formation. Since dexamethasone is commonly used in myeloma treatment regimens, this is a real concern worth discussing with your care team.
Other myeloma treatments can also affect the eyes in different ways:
- Bortezomib (Velcade) has been linked to eye-related side effects
- Immunomodulatory drugs (like lenalidomide/Revlimid) can increase infection risk, including eye infections
- Myeloma itself can directly affect the eyes through plasmacytoma formation or hyperviscosity (thickening of the blood)
It's important not to make any changes to your treatment plan without speaking to your oncology team first, even if you suspect a medication is affecting your eyes.
Regular eye check-ups are a good idea, and flagging any vision changes — like blurring, glare sensitivity, or cloudy vision — to your doctor promptly is strongly recommended.
April 26
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
